Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Lean people had a higher mortality rate despite experiencing fewer metabolic problems.
Competition to claim a market has triggered a wave of advertising that has provoked the concern of regulators and doctors worldwide.
BMI may not be the best way to assess health risks linked to excess weight.
Most outcomes were similar in lean and heavy people with fatty liver disease, but the lean group had higher liver-related mortality.
Some 20% of those with NAFLD also showed signs of liver fibrosis.
The weight-to-height ratio, never meant as a diagnostic tool, is used to determine insurance coverage of weight loss therapies.
Advanced stages of NAFLD were more commonly seen in people whose mothers had obesity or overweight during pregnancy.
With every centimeter increase in waist circumference, the risk of severe fibrosis rose by 5%.
That means the Alaskan man, who contracted hepatitis C in 1976, and his shi tzu walked a distance equal to a lap around the Earth.
Study finds that lean people with NAFLD had a higher risk for liver events, cancer and mortality.
Weight loss, exercise and a healthy diet are keys to managing type 2 diabetes.
People treated with semaglutide for 68 weeks lost an average of 14.9% of their initial body weight.
Excess weight, which is often linked to metabolic abnormalities, can contribute to a wide variety of health problems.
Weight-loss surgery especially reduced obesity-related cancers in people with liver cirrhosis.
People with both obesity and liver steatosis were at greater risk for hospitalization with COVID-19.
The disease has similar prevalence across high-income and low- and middle-income nations.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.